AHR and chronic kidney disease: Disorders of gut-derived metabolites, including p-cresyl sulfate, indoxyl sulfate, indole-3-acetic acid (IAA), and indole-3-aldehyde (IAld), drive kidney injury in AKI and CKD by activating aryl hydrocarbon receptor (AhR) pathways and promoting inflammation/fibrosis (34).